House Bill 6 Summary

• Clarifies Board of Pharmacy authority to designate, add, delete, or reschedule controlled substances pursuant to administrative procedures in chapter 52, title 67.

• Allows the Board to respond to federal controlled substance designations by promulgating temporary rules or proposing statutory amendments within 30 days of Federal Register publication, rather than waiting for expiration periods.

• Revises Schedule I controlled substances list to add u-47700 (an opioid analog) and updates hallucinogenic substance definitions including synthetic cannabinoids and cathinone derivatives.

• Updates Schedule III, IV, and V controlled substances lists with technical corrections and additions including perampanel, brivaracetam, ezogabine, lacosamide, and pregabalin.

• Declares an emergency, making the act effective immediately upon passage and approval.